XML 42 R24.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Options (Tables)
12 Months Ended
Aug. 31, 2019
Stock Options Tables  
Assumptions

The Company employs the following key weighted-average assumptions in determining the fair value of stock options, using the Black-Scholes option pricing model and the simplified method to estimate the expected term of “plain vanilla” options:

 

   Years Ended August 31,
   2019  2018
Expected dividend yield          
Expected stock price volatility  87.42 87.84%  83.43% 83.55%
Risk-free interest rate    1.84%    2.27% - 2.33%
Expected term (in years)  4.5 5.0    7.67  
Exercise price    $3.54    $4.87 - $5.35
Weighted-average grant date fair-value  $2.35 $2.43  $3.76 - $5.64
Stock option activity

A summary of the Company’s stock option activity for the years ended August 31, 2019 and 2018 and related information follows:

 

   Number of Shares Subject to Option Grants  Weighted Average Exercise Price ($)  Weighted Average Remaining Contractual Term (years)  Aggregate Intrinsic Value ($)
Outstanding at August 31, 2017   2,125,001    2.84           
Grants   1,263,000    5.25           
Exercises   (291,667)   3.32           
Forfeitures and cancellations   (1,805,000)   2.74           
Outstanding at August 31, 2018   1,291,334    5.22           
Grants   1,506,000    3.54           
Forfeitures and cancellations   (20,000)   4.87           
Outstanding at  August 31, 2019   2,777,334    4.31    8.33    0 
Exercisable at  August 31, 2019   1,716,234    4.17    9.00    0 
Share-based compensation cost

The following table sets forth the share-based compensation cost resulting from stock option grants, including those previously granted and vesting over time, that were recorded in the Company’s Statements of Operations for the years ended August 31, 2019 and 2018:

 

   Years ended August 31,
   2019  2018
Stock based compensation expense related to the following:          
Stock Options:          
SG&A  $2,993,532   $1,018,351 
R&D   965,835    796,974 
Total   3,959,367    1,815,325 
Restricted stock issuances:          
SG&A   -    1,022,700 
R&D   -    - 
Total   -    1,022,700 
Total stock based compensation expense  $3,959,367   $2,838,025 
Stock options outstanding and exercisable

The following table summarizes information about stock options outstanding and exercisable at August 31, 2019:

 

   Stock Options Outstanding  Stock Options Exercisable
Range of
Exercise
Prices
  Number of Shares
Subject to
Outstanding Options
  Weighted
Average
Contractual
Life (years)
  Weighted
Average
Exercise
Price ($)
  Number
of Shares Subject
To Options
Exercise
  Weighted Average
Remaining
Contractual
Life (Years)
  Weighted
Average
Exercise
Price ($)
                               
3.28   7,500    7.21    3.28    7,500    7.21    3.28 
3.46   35,000    6.35    3.46    35,000    6.35    3.46 
3.54   1,506,000    8.53    3.54    1,032,900    9.76    3.54 
4.87   187,500    8.23    4.87    187,500    8.23    4.87 
5.35   1,008,000    8.35    5.35    420,000    8.35    5.35 
5.94   33,334    1.32    5.94    33,334    1.32    5.94 
Total   2,777,334    8.33    4.31    1,716,234    9.00    4.17